Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

Clinical trial NCT05318469 · RECRUITING

Trial details

NCT number: NCT05318469
Sponsor: Yuan Yuan
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Triple-Negative Breast Carcinoma

Start date: 2023-10-13
Primary completion: 2026-10-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.